Combinatorial chemistry by ant colony optimization

Future Medicinal Chemistry

Volumn 6, Issue 3, 2014, Pages 267-280

  Hiss, Jan A ^a   Reutlinger, Michael ^a   Koch, Christian P ^a   Perna, Anna M ^a   Schneider, Petra ^a   Rodrigues, Tiago ^a   Haller, Sarah ^a   Folkers, Gerd ^a,b   Weber, Lutz ^c   Baleeiro, Renato B ^d   Walden, Peter ^d   Wrede, Paul ^d   Schneider, Gisbert ^a  

^a ETH ZURICH   (Switzerland)

^b Swiss Federal Institute of Technology Collegium Helveticum   (Switzerland)

^c OntoChem GmbH   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A INHIBITOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OCTAPEPTIDE; PEPTIDE;

ALGORITHM; ANT COLONY OPTIMIZATION; ARTICLE; BINDING AFFINITY; COMBINATORIAL CHEMISTRY; COMPUTER ANALYSIS; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN PROTEIN INTERACTION; RETROSPECTIVE STUDY;

ALGORITHMS; AMINO ACID SEQUENCE; ANIMALS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; FACTOR XA; H-2 ANTIGENS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES;

EID: 84895460947     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.13.203     Document Type: Article

References (51)

1. Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Synthetic therapeutic peptides: Science and market. Drug Discov. Today 15, 40-56 (2010).
2. Audie J, Boyd C. The synergistic use of computation, chemistry and biology to discover novel peptide-based drugs: The time is right. Curr. Pharm. Des. 16, 567-582 (2010).
3. Fjell CD, Hiss JA, Hancock REW, Schneider G. Designing antimicrobial peptides: Form follows function. Nat. Rev. Drug Discov. 11, 37-51 (2011).
4. Rentero I, Heinis C. Screening of large molecule diversities by phage display. Chimia 65, 843-845 (2011).
5. Pande J, Szewczyk MM, Grover AK. Phage display: Concept, innovations, applications and future. Biotechnol. Adv. 28, 849-858 (2010).
6. Schneider G, Schrödel W, Wallukat G et al. Peptide design by artificial neural networks and computer-based evolutionary search. Proc. Natl Acad. Sci. USA 95, 12179-12184 (1998).
7. Rechenberg I. Optimierung technischer Systeme nach Prinzipien der biologischen Evolution. Frommann-Holzboog, Stuttgart, Germany (1973).
8. Johnson MA, Maggiora GM. Concepts and Applications of Molecular Similarity. Wiley, NY, USA (1990).
9. Schneider G, Hartenfeller M, Reutlinger M, Tanrikulu Y, Proschak E, Schneider P. Voyages to the (un)known: Adaptive design of bioactive compounds. Trends Biotechnol. 27, 18-26 (2009).
10. Schneider G, So SS. Adaptive Systems in Drug Design. Landes Bioscience, Washington DC, USA (2003).
11. Hiss JA, Hartenfeller M, Schneider G. Concepts and applications of natural computing techniques in de novo drug and peptide design. Curr. Pharm. Des. 16, 1656-1665 (2010).
12. Daeyaert F, De Jonge M, Koymans L, Vinkers M. An ant algorithm for the conformational analysis of flexible molecules. J. Comput. Chem. 28, 890-898 (2007).
13. Dorigo M, Di Caro G. Ant colony optimization: A new meta-heuristic. Proc. CEC 99 2, 1470-1477 (1999).
14. Dorigo M, Blum C. Ant colony optimization theory: A survey. Theor. Comput. Sci. 344, 243-278 (2005).
15. Schneider P, Schneider G. Collection of bioactive reference compounds for focused library design. QSAR Comb. Sci. 22, 713-718 (2003).
16. Koch CP, Perna AM, Pillong M et al. Scrutinizing MHC-I binding peptides and their limits of variation. PLoS Comput. Biol. 9, e1003088 (2013).
17. Koch CP, Perna AM, Weissmüller S et al. Exhaustive proteome mining for functional MHC-I ligands. ACS Chem. Biol. 8, 1876-1881 (2013).
18. Rammensee HG, Bachmann J, Emmerich NPN, Bachor OA, Stevanović S. SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219 (1999).
19. Schneider G, Wrede P. Artificial neural networks for computer-based molecular design. Prog. Biophys. Mol. Biol. 70, 175-222 (1998).
20. Hinton G, Roweis S. Stochastic neighbor embedding. NIPS 15, 833-840 (2002).
21. Reutlinger M, Schneider G. Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery. J. Mol. Graph. Model. 108-117 (2012).
22. Schneider TD, Stephens RM. Sequence logos: A new way to display consensus sequences. Nucleic Acids Res. 18, 6097-6100 (1990).
23. Brock R, Wiesmüller KH, Jung G, Walden P. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc. Natl Acad. Sci. USA 93, 13108-13113 (1996).
24. Rötzschke O, Falk K, Stevanović S, Jung G, Walden P, Rammensee HG. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21, 2891-2894 (1991).
25. Wisniewska JM, Jäger N, Freier A et al. MHC I stabilizing potential of computer-designed octapeptides. J. Biomed. Biotechnol. 396847 (2010).
26. Ugi I, Meyr R, Fetzer U, Steinbrückner C. Versuche mit Isonitrilen. Angew. Chem. 71, 386 (1959).
27. Pan SC, List B. Catalytic three-component Ugi reaction. Angew. Chem. Int. Ed. 47, 3622-3625 (2008).
28. Yokobayashi Y, Ikebukuro K, McNiven S, Karube I. Directed evolution of trypsin inhibiting peptides using a genetic algorithm. J. Chem. Soc. Perkin Trans. 1, 2435-2437 (1996).
29. Weber L, Wallbaum S, Gubernator K, Broger C. Optimization of the biological activity of combinatorial compound libraries by a genetic algorithm. Angew. Chem. Int. Ed. 34, 2280-2282 (1995).
30. Fechner U, Schneider G. Flux (1): A virtual synthesis scheme for fragment-based de novo design. J. Chem. Inf. Model. 46, 699-707 (2006).
31. Riester D, Wirsching F, Salinas G et al. Thrombin inhibitors identified by computer-Assisted multiparameter design. Proc. Natl Acad. Sci. USA 102, 8597-8602 (2005).
32. Sinauridze EI, Romanov AN, Gribkova IV et al. New synthetic thrombin inhibitors: Molecular design and experimental verification. PLoS ONE 6, e19969 2011.
33. Illgen K, Enderle T, Broger C, Weber L. Simulated molecular evolution in a full combinatorial library. Chem. Biol. 7, 433-441 (2000).
34. Illgen K, Nerdinger S, Fuchs T, Friedrich C, Weber L, Herdtweck E. A versatile synthesis of 6-oxo-1, 4, 5, 6-Tetrahydro-pyrazine-2-carboxylic acid methyl esters via MCR chemistry. Synlett 15, 53-56 (2004).
35. De Candia M, Lopopolo G, Altomare C. Novel factor Xa inhibitors: A patent review. Expert Opin. Ther. Pat. 19, 1535-1580 (2009).
36. Schüller A, Schneider G. Identification of hits and lead structure candidates with limited resources by adaptive optimization. J. Chem. Inf. Model. 48, 1473-1491 (2008).
37. Agrafiotis DK. Stochastic algorithms for maximizing molecular diversity. J. Chem. Inf. Comput. Sci. 37, 841-851 (1997).
38. Zheng W, Cho SJ, Waller CL, Tropsha A. Rational combinatorial library design. 3. Simulated Annealing Guided Evaluation (SAGE) of molecular diversity: A novel computational tool for universal library design and database mining. J. Chem. Inf. Comput. Sci. 39, 738-746 (1999).
39. Stützle T, Hoos HH. MAX-MIN ant system. Fut. Generat. Comput. Sys. 16, 889-914 (2000).
40. Dorigo M, Maniezzo V, Colorni A. Ant system: Optimization by a colony of cooperating agents. IEEE Trans. Syst. Man Cybern. 26, 29-41 (1996).
41. Dorigo M, Gambardella LM. Ant colony system: A cooperative learning approach to the traveling salesman problem. IEEE Trans. Evol. Comput. 1, 53-66 (1997).
42. Cortes C, Vapnik V. Support-vector networks. Mach. Learn. 20, 273-297 (1995).
43. Rumelhart DE, Hintont GE, Williams RJ. Learning representations by back-propagating errors. Nature 323, 533-536 (1986).
44. van der Maaten LJP, Postma EO, van den Herik HJ. Matlab toolbox for dimensionality reduction. MICC, Maastricht University (2007).
45. Crooks GE, Hon G, Chandonia M, Brenner SE. WebLogo: A sequence logo generator. Genome Res. 14, 1188-1190 (2004).
46. Udaka K, Wiesmüller KH, Kienle S, Jung G, Walden P. Tolerance to amino acid variations in peptides binding to the major histocompatibility complex class I protein H-2Kb. J. Biol. Chem. 270, 24130-24134 (1995).
47. Ljunggren HG, Kärre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J. Exp. Med. 162, 1745-1759 (1985).
48. Köhler G, Fischer Lindahl K, Heusser C. Characterization of a monoclonal anti-H-2Kb antibody. In: Immune System. Steinberg CM, Lefkovits I (Eds). S Karger AG, Basel, Switzerland, 202 (1981).
49. Engelbrecht AP. Fundamentals of Computational Swarm Intelligence. Wiley, NY, USA (2005).
50. Hiss JA, Bredenbeck A, Losch FO, Wrede P, Walden P, Schneider G. Design of MHC I stabilizing peptides by agent-based exploration of sequence space. Protein Eng. Des. Sel. 20, 99-108 (2007).
51. Jäger N, Wisniewska JM, Hiss JA et al. Attractors in sequence space: Agent-based exploration of MHC I binding peptides. Mol. Inf. 29, 65-74 (2010).